Gary C Calandra
Impact in
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Virology top 5%
- HIV Research and Treatment
Papers in
- Hematology 28
- Hematopoietic Stem Cell Transplantation 21
- Multiple Myeloma Research and Treatments 19
- Acute Myeloid Leukemia Research 14
- Oncology 10
- Chemokine receptors and signaling 7
- Co-authors
- Gary J Bridger (17 shared papers)Karin Badel (11 shared papers)John F. DiPersio (11 shared papers)Stefan Früehauf (7 shared papers)Patrick J. Stiff (8 shared papers)Ivana N. Micallef (8 shared papers)Auayporn P. Nademanee (5 shared papers)Richard Thomas Maziarz (6 shared papers)
- Journals
- Blood (20 papers)Bone Marrow Transplantation (4 papers)Transplantation and Cellular Therapy (3 papers)Antiviral Research (1 paper)Cytotherapy (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Gary C Calandra
37 papers receiving 1.7k citations
Gary C Calandra's Hit Papers
Peers
Comparison fields: 5 of 66
- Hematology 1.1k
- Virology 119
- Oncology 641
- Immunology 470
- Genetics 173
Countries citing papers authored by Gary C Calandra
This map shows the geographic impact of Gary C Calandra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary C Calandra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary C Calandra more than expected).
Fields of papers citing papers by Gary C Calandra
This network shows the impact of papers produced by Gary C Calandra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary C Calandra. The network helps show where Gary C Calandra may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary C Calandra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma Hit paper breakdown → | 2009 | 654 |
| 2 | 2004 | 310 | |
| 3 | 2007 | 240 | |
| 4 | 2009 | 77 | |
| 5 | 2009 | 69 | |
| 6 | 2009 | 53 | |
| 7 | 2006 | 52 | |
| 8 | 2007 | 45 | |
| 9 | 2010 | 40 | |
| 10 | 2007 | 28 | |
| 11 | 2010 | 25 | |
| 12 | 2006 | 25 | |
| 13 | 2007 | 23 | |
| 14 | 2007 | 21 | |
| 15 | 2009 | 19 | |
| 16 | 2012 | 14 | |
| 17 | 2004 | 14 | |
| 18 | 2007 | 12 | |
| 19 | 2009 | 11 | |
| 20 | 2012 | 8 |
About Gary C Calandra
Gary C Calandra is a scholar working on Hematology, Oncology, Immunology, Genetics and Pathology and Forensic Medicine, having authored 37 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (21 papers), Multiple Myeloma Research and Treatments (19 papers), Acute Myeloid Leukemia Research (14 papers), Chemokine receptors and signaling (7 papers), Immunotherapy and Immune Responses (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and HIV/AIDS drug development and treatment (3 papers). The work is most often cited by research in Hematology (1.1k citations), Virology (119 citations), Oncology (641 citations), Immunology (470 citations) and Genetics (173 citations). Gary C Calandra has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Gary J Bridger, Karin Badel, John F. DiPersio, Stefan Früehauf, Patrick J. Stiff, Ivana N. Micallef, Auayporn P. Nademanee, Richard Thomas Maziarz, Edward Allen Stadtmauer and Guido J. K. Tricot. Their work appears in journals such as Blood, Bone Marrow Transplantation, Transplantation and Cellular Therapy, Antiviral Research and Cytotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.